About the course
Key updates in the new regulation of Pharmaceuticals and Medical Devices Agency (PMD)
- Key points of the amendment of the PMD Act
- Future area of guidance D21
- Challenges and opportunities for industry to create favorable environment in expediting B21approval of medicines
- GMP developments and implementation of ICHQ3D in Japan
- Japanese Pharmacopoeia amendment JP18 and updates